Clinical Trials Browser

Phase EARLY_PHASE1 × enfortumab vedotin × 90 days × Clear all

NCT06204614 2026-05-18

Drug Screening Using IMD in Bladder Cancer

Phase EARLY_PHASE1 Enrolling by invitation

Muscle Invasive Bladder Urothelial Carcinoma